Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections

Background: Emerging data suggest that more aggressive beta-lactam PK/PD targets could minimize the occurrence of microbiological failure and/or resistance development. This study aims to assess whether a PK/PD target threshold of continuous infusion (CI) beta-lactams may be useful in preventing mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Cojutti, Pier Giorgio, Pascale, Renato, Tonetti, Tommaso, Laici, Cristiana, Dell’Olio, Alessio, Siniscalchi, Antonio, Giannella, Maddalena, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615220/
https://www.ncbi.nlm.nih.gov/pubmed/34827249
http://dx.doi.org/10.3390/antibiotics10111311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615220/
https://www.ncbi.nlm.nih.gov/pubmed/34827249
http://dx.doi.org/10.3390/antibiotics10111311

Ejemplares similares